Sivin I, Stern J. Health during prolonged use of levonorgestrel 20 micrograms/d and the copper TCu 380A intrauterine contraceptive devices: a multicenter study. Fertil Steril 1994;61:70–77.
59.
El Badrawi HH, Hafez ES, Barnhart MI, et al. Ultrastructural changes in human endometrium with copper and nonmedicated IUDs in utero. Fertil Steril 1981;36:41–49.
60.
Umapathysivam K, Jones WR. Effects of contraceptive agents on the biochemical and protein composition of human endometrium. Contraception 1980;22:425–440.
61.
Mirena Full Prescribing Information. Bayer Healthcare. Pharmaceuticals, 2009.
62.
Rose S, Chaudhari A, Peterson CM. Mirena (levonorgestrel intrauterine system): successful novel drug delivery option in contraception. Adv Drug Del Rev 2009;61:808–812.
63.
Stanford JB, Mikolajczyk RT. Mechanism of action of the intrauterine device: update and estimation of post fertilization effect. Am J Obstet Gynecol 2002;187:1699–1708.
64.
Alvarez F, Guiloff E, Brache V, et al. New insights on the mode of action of intrauterine devices in women. Fertil Steril 1989;49:768– 773.
65.
Segal S, Alvarez-Sanchez F, Adejeuwon CA, et al. Absence of chorionic gonadotropin in sera of women who use intrauterine devices. Fertil Steril 1985;44:214–218.
66.
Anonymous. Long term reversible contraception. Twelve years experience with the TCU380A and TCU220C. Contraception 1997; 56:341–352.
67.
Irvine GA, Campbell-Brown MB, Lumsden MA, et al. Randomized comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia. BJOG 1998;10:592–598.
68.
Magalhaes J, Aldrighi JM, de Lima GR. Uterine volume and menstrual patters in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas. Contraception 2007;75:193–198.
69.
Rizkalla HF, Higgins M, Kelehan P, et al. Pathological findings associated with the presence of a Mirena intrauterine system at hysterectomy. Int J Gynecol Pathol 2008;27:74–78.
70.
Suhonen SP, Holmstr¨om T, Allonen HO, et al. Intrauterine and subdermal progestin administration in postmenopausal hormone replacement therapy. Fertil Steril 1995;63:336–342.
71.
Hill DA, Weiss NS, Voigt LF, et al. Endometrial cancer in relation to intrauterine device use. Int J Cancer 1997;70:278–281.
72.
Vercellini P. A levonorgestrel-releasing intrauterine system for the treatment of dysmenorrheal associated with endometriosis: a pilot study. Fertil Steril 1999;72:505–508.
73.